INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $946,844 | +6.8% | 25,405 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $886,380 | -79.9% | 25,405 | -67.8% | 0.00% | -83.3% |
| Q3 2022 | $4,415,000 | +182.1% | 78,897 | +160.9% | 0.01% | +500.0% |
| Q2 2022 | $1,565,000 | -57.9% | 30,236 | +9.1% | 0.00% | -66.7% |
| Q3 2021 | $3,719,000 | -82.4% | 27,722 | -78.7% | 0.00% | -83.3% |
| Q2 2021 | $21,096,000 | +2273.0% | 130,301 | +191.5% | 0.02% | +1700.0% |
| Q3 2020 | $889,000 | +15.0% | 44,700 | +58.0% | 0.00% | 0.0% |
| Q2 2018 | $773,000 | +1785.4% | 28,295 | +1221.0% | 0.00% | – |
| Q4 2017 | $41,000 | – | 2,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |